Skip to main content
. Author manuscript; available in PMC: 2014 Feb 5.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 May 22;63(3):517–524. doi: 10.1007/s00280-008-0769-8

Fig. 4.

Fig. 4

Plasma concentration-time profile, in a representative patient of with no evidence of enterohepatic recirculation, for irinotecan (filled circle), SN-38 (open circle), and APC (inverted triangle). Symbols represent measured plasma concentration, and solid lines are obtained from point by point connection of the predicted plasma concentrations by the standard model